probenecid has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantengwa, S | 1 |
| Capponi, AM | 1 |
| Bonventre, JV | 1 |
| Polla, BS | 1 |
1 other study available for probenecid and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Calcium and the heat-shock response in the human monocytic line U-937.
Topics: Benzofurans; Calcitriol; Calcium; Cell Line; Cell Survival; Fluorescent Dyes; Fura-2; Heat-Shock Pro | 1990 |